Literature DB >> 7380991

The role of endogenous opiates in LH secretion during the menstrual cycle.

M E Quigley, S S Yen.   

Abstract

To determine whether endogenous opiates exert an inhibitory action on LH secretion during the menstrual cycle, LH increments were examined in response to a specific opiate antagonist, naloxone, infused at 1.6 mg/hr for 4 hrs. Naloxone had no discernible effect on LH release during the early follicular phase. By contrast, a significant LH increment was observed in both the late follicular and mid-luteal phases of the cycle but the patterns of LH increment were distinct. Late follicular subjects exhibited slow, progressive increases in LH, while prompt, episodic and quantitatively greater LH increments were evident in mid-luteal phase subjects. These observations suggest that endogenous opiates are involved in the regulation of LH secretion during the high estrogen and estrogen-progesterone phases of the menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380991     DOI: 10.1210/jcem-51-1-179

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

1.  Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea.

Authors:  A D Genazzani; M Stomati; C Bersi; S Luisi; M Fedalti; M Santuz; G Esposito; F Petraglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

Review 2.  Exercise and secondary amenorrhoea linked through endogenous opioids.

Authors:  M T Ruffin; R E Hunter; E A Arendt
Journal:  Sports Med       Date:  1990-08       Impact factor: 11.136

3.  Gonadal steroids do not affect basal growth hormone response to naloxone in humans.

Authors:  P Monteleone; M Maj; M Iovino; L Fiorenza; P M Fiumani; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  The pineal gland-opioid system relation: melatonin-naloxone interactions in regulating GH and LH releases in man.

Authors:  D Esposti; P Lissoni; R Mauri; F Rovelli; L Orsenigo; S Pescia; G Vegetti; G Esposti; F Fraschini
Journal:  J Endocrinol Invest       Date:  1988-02       Impact factor: 4.256

Review 5.  The interaction between mediobasohypothalamic dopaminergic and endorphinergic neuronal systems as a key regulator of reproduction: an hypothesis.

Authors:  D D Rasmussen
Journal:  J Endocrinol Invest       Date:  1991-04       Impact factor: 4.256

6.  Evidence that the arcuate nucleus is an important site of progesterone negative feedback in the ewe.

Authors:  Robert L Goodman; Ida Holaskova; Casey C Nestor; John M Connors; Heather J Billings; Miro Valent; Michael N Lehman; Stanley M Hileman
Journal:  Endocrinology       Date:  2011-06-21       Impact factor: 4.736

7.  Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.

Authors:  P Fioretti; A Cagnacci; A M Paoletti; M Gambacciani; R Soldani; G A Mauro; A Spinetti; G B Melis
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

8.  Effect of dopamine receptor stimulation on the inhibition of LH pulsatility by a met-enkephaline (FK 33-824).

Authors:  E del Pozo; J Martin-Perez
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

9.  The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration.

Authors:  A M Fulghesu; A Lanzone; R Apa; M Guido; M Ciampelli; F Cucinelli; A Caruso; S Mancuso
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

10.  The effects of prolonged opioidergic blockade on LH pulsatile secretion during the menstrual cycle.

Authors:  W G Rossmanith; U Wirth; K Sterzik; S S Yen
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.